Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosed with predisposing condition causing ARDS~* are mechanically ventilated through an endotracheal tube~* have enteral feeding access~* have central venous access~* have a PaO2:FiO2 ratio of less than 200~* have bilateral pulmonary infiltrates on chest x-ray~Exclusion Criteria:~* sedation requiring the use of diprivan (after enrollment)~* a clinical diagnosis of left ventricular failure~* lung cancer~* hematologic malignancy~* severe dyslipidemia~* condition precluding bronchoscopy including inability to maintain oxygen saturations greater than 90% per pulse oximetry despite conventional mechanical ventilation~* severe immunosuppression~* use of NSAIDS within previous 24 hours~* HIV positive~* pregnancy~* hypersensitivity to egg or soybean oil~* active myocardial infarction~* acute pancreatitis if complicated by hypertriglyceridemia~* severe sepsis with 2 or more organ failures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- ClinOleic 20% (Type: EXPERIMENTAL): 96 hour continuous infusion.
- Intralipid 20% (Type: ACTIVE_COMPARATOR): 96 hour continuous infusion.

Based on this trial design, predict the completion outcome and termination type (if applicable).